Jessica Pearce

Jessica Pearce

Auto-generated profile, based on publicly available information

Jessica Pearce

Leeds Institute of Medical Research at St James’, University of Leeds , Leeds

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2025 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
JPJessica Pearce
Jessica Pearce
SMSally Martin
Sally Martin
SHSophie Heritage
Sophie Heritage
Emma G KhouryEmma G Khoury
Emma G Khoury
JKJoanna Kucharczak
Joanna Kucharczak
AGAlexandra Gilbert
Alexandra Gilbert
Background: It is increasingly recognized that frailty should be assessed and considered in treatment decision making in patients with cancer. This review and meta-analysis synthesizes existing evidence evaluating the association between baseline frailty and systemic anticancer treatment outcomes in adults with cancer. Methods: Five databases were systematically searched from database inception to January 2023 to identify prognostic factor studies (cohort or case-control design) reporting the associations between validated frailty assessments (pretreatment) and follow-up outcomes in adults with solid-organ malignancy undergoing systemic anticancer treatment. Risk of bias was assessed via Quality of Prognosis Studies in Systematic Reviews tool. Where appropriate, associations between frailty and outcomes (survival, toxicity, treatment tolerance, functional decline/quality of life, and hospitalization) were synthesized in meta-analysis and presented as forest plots. Results: A total of 58 studies met inclusion criteria. They were undertaken in a range of tumor sites and mainly in older patients and advanced and/or palliative disease settings. Most had low or moderate risk of bias. Nine frailty assessment tools were evaluated. Four outcomes were synthesized in meta-analysis, which demonstrated the prognostic value of 2 tools: Geriatric-8 (survival, treatment tolerance, hospitalization) and Vulnerable Elders Survey-13 (survival, toxicity, treatment tolerance). Overall pooled estimates indicate that frailty conveys an increased risk of mortality (hazard ratio [HR] = 1.68, 95% confidence interval [CI] = 1.41 to 2.00), toxicity (odds ratio [OR] 1.83, 95% CI = 1.24 to 2.68), treatment intolerance (OR = 1.68, 95% CI = 1.32 to 2.12), and hospitalization (OR = 1.94, 95% CI = 1.32 to 2.83). Conclusion: Simple, brief frailty assessments including Geriatric-8 and Vulnerable Elders Survey-13 are prognostic for a range of important outcomes in patients undergoing systemic anticancer treatment. Risk estimates should be used to support shared decision making.

26 July 2017 in Medical Education
Verified
Journal Article
Closed access
PDF file
MRMelody Redman
Melody Redman
JPJessica Pearce
Jessica Pearce
SGSareena Gajebasia
Sareena Gajebasia
MJMiriam Johnson
Miriam Johnson
GFGabrielle M. Finn
Gabrielle M. Finn

1 September 2023 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
KSKatie L. Spencer
Katie L. Spencer
KAKate L. Absolom
Kate L. Absolom
MAMatthew Allsop
Matthew Allsop
SRSamuel D. Relton
Samuel D. Relton
JPJessica Pearce
Jessica Pearce
SVSabine N. van der Veer
Sabine N. van der Veer
PURPOSE: This discussion paper outlines challenges and proposes solutions for successfully implementing prediction models that incorporate patient-reported outcomes (PROs) in cancer practice.METHODS: We organized a full-day multidisciplinary meeting of people with expertise in cancer care delivery, PRO collection, PRO use in prediction modeling, computing, implementation, and decision science. The discussions presented here focused on identifying challenges to the development, implementation and use of prediction models incorporating PROs, and suggesting possible solutions.RESULTS: Specific challenges and solutions were identified across three broad areas. (1) Understanding decision making and implementation: necessitating multidisciplinary collaboration in the early stages and throughout; early stakeholder engagement to define the decision problem and ensure acceptability of PROs in prediction; understanding patient/clinician interpretation of PRO predictions and uncertainty to optimize prediction impact; striving for model integration into existing electronic health records; and early regulatory alignment. (2) Recognizing the limitations to PRO collection and their impact on prediction: incorporating validated, clinically important PROs to maximize model generalizability and clinical engagement; and minimizing missing PRO data (resulting from both structural digital exclusion and time-varying factors) to avoid exacerbating existing inequalities. (3) Statistical and modeling challenges: incorporating statistical methods to address missing data; ensuring predictive modeling recognizes complex causal relationships; and considering temporal and geographic recalibration so that model predictions reflect the relevant population.CONCLUSION: Developing and implementing PRO-based prediction models in cancer care requires extensive multidisciplinary working from the earliest stages, recognition of implementation challenges because of PRO collection and model presentation, and robust statistical methods to manage missing data, causality, and calibration. Prediction models incorporating PROs should be viewed as complex interventions, with their development and impact assessment carried out to reflect this.

12 February 2019 in The Clinical Teacher
Verified
Journal Article
Closed access
PDF file
SGSareena Gajebasia
Sareena Gajebasia
JPJessica Pearce
Jessica Pearce
MRMelody Redman
Melody Redman
MJMiriam Johnson
Miriam Johnson
GFGabrielle M. Finn
Gabrielle M. Finn

17 April 2018 in The Clinical Teacher
Verified
Journal Article
Closed access
PDF file
JPJessica Pearce
Jessica Pearce
MRMelody Redman
Melody Redman
SGSareena Gajebasia
Sareena Gajebasia
RDRuth Dirksen
Ruth Dirksen

1 February 2019 in Future Healthcare Journal
Verified
Journal Article
Open access
PDF file
JPJessica Pearce
Jessica Pearce
SGSameet Govan
Sameet Govan
AHAnna Harlinska
Anna Harlinska
RTRebecca Tremain
Rebecca Tremain
SGSareena Gajebasia
Sareena Gajebasia
MRMelody Redman
Melody Redman
Newly graduated doctors may be expected to conduct ward rounds alone, yet studies exploring this are limited. A regional cross-sectional study was undertaken to explore foundation year 1 doctors’ (FY1s) experiences of conducting ward rounds alone; all 289 FY1s on medical rotations in Yorkshire and the Humber Foundation School were invited to participate in an online survey in November 2016. Thirty-four percent (n=98) responded. The majority (62%, n=61) of respondents reported conducting the daily ward round alone (without a more senior doctor present) two or more times a week. However, 56% (n=55) reported that they had never received teaching on ward round conduct and only 7% (n=7) reported feeling prepared for conducting ward rounds alone at the start of their medical rotation. FY1-led ward rounds are a regular occurrence yet training is not commonplace; widespread, early training should be considered to prepare future doctors for their role.